References
- Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin- converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706–11
- Schut AF, Bleumink GS, Stricker BH, Hofman A, Witteman JC, Pols HA, et al. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects. Eur Heart J 2004; 25: 2143–8
- Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A, et al. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996; 50: 657–64
- Samuelsson O, Attman PO, Larsson R, Mulec H, Rymo L, Weiss L, et al. Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease. Nephrol Dial Transplant 2000; 15: 481–6
- MacGregor GA, Markandu ND, Roulston JE, Jones JC, Morton JJ. Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature 1981; 291: 329–31
- Bader M, Wagner J, Lee MA, Ganten D. The role of the renin-angiotensin system in cardiovascular disease. Hypertens Res 1994; 17: 1–16
- Nagahara T, Ishigami T, Sano T, Ikeda Y, Hibi K, Uneda S, et al. Angiotensin-converting enzyme gene insertion/deletion polymorphism and left ventricular hypertrophy in hemodialysis patients. Jpn Heart J 1997; 38: 821–30
- Osono E, Kurihara S, Hayama N, Sakurai Y, Ohwada K, Onoda N, et al. Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease. Am J Kidney Dis 1998; 32: 725–30
- Losito A, Kalidas K, Santoni S, Ceccarelli L, Jeffery S. Polymorphism of renin-angiotensin system genes in dialysis patients—association with cerebrovascular disease. Nephrol Dial Transplant 2002; 17: 2184–8
- Ishimitsu T, Tsukada K, Ohta S, Inada H, Minami J, Ono H, et al. Increased cardiovascular risk in long-term hemodialysis patients carrying deletion allele of ACE gene polymorphism. Am J Kidney Dis 2004; 44: 466–75
- Kohse KP, Feifel K, Mayer-Wehrstein R. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients. Clin Nephrol 1993; 40: 83–90
- Haug C, Metzele A, Steffgen J, Grunert A. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure. Horm Metab Res 1994; 26: 246–9
- Ishizaka Y, Yamamoto Y, Fukunaga T, Yokota N, Kida O, Kitamura K, et al. Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Am J Kidney Dis 1994; 24: 461–72
- Mallamaci F, Zoccali C, Tripepi G, Benedetto FA, Parlongo S, Cataliotti A, et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 2001; 59: 1559–66
- Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12: 1508–15
- Parfrey PS, Collingwood P, Foley RN, Bahrle A. Left ventricular disorders detected by M-mode echocardiography in chronic uraemia. Nephrol Dial Transplant 1996; 11: 1328–31
- Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of survey of echocardiographic measurements. Circulation 1978; 58: 1072–83
- Shanmugan V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Meth Appl 1993; 3: 120–1
- Friedl W, Mair J, Pichler M, Paulweber B, Sandhofer F, Puschendorf B. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene is associated with atrial natriuretic peptide activity after exercise. Clin Chim Acta 1998; 274: 199–211
- Danser AH, Derkx FH, Hense HW, Jeunemaitre X, Riegger GA, Schunkert H. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels. J Hypertens 1998; 16: 1879–83
- Volpe M, Tritto C, DeLuca N, Rubattu S, Mele AF, Lembo G, et al. Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure. Circulation 1992; 86: 1800–9
- Willenbrock R, Scheuermann M, Thibault G, Haass M, Hohnel K, Bohlender J, et al. Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt. Cardiovasc Res 1999; 42: 733–42
- Marttila M, Vuolteenaho O, Ganten D, Nakao K, Ruskoaho H. Synthesis and secretion of natriuretic peptides in the hypertensive TGR (mREN-2)27 transgenic rats. Hypertension 1996; 28: 995–1004